nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—esophageal cancer	0.383	1	CbGbCtD
Zaleplon—Gingivitis—Methotrexate—esophageal cancer	0.00175	0.0044	CcSEcCtD
Zaleplon—Irritability—Cisplatin—esophageal cancer	0.00173	0.00436	CcSEcCtD
Zaleplon—Neuropathy—Capecitabine—esophageal cancer	0.00173	0.00435	CcSEcCtD
Zaleplon—Dry eye—Capecitabine—esophageal cancer	0.0017	0.00428	CcSEcCtD
Zaleplon—Oesophagitis—Capecitabine—esophageal cancer	0.00168	0.00424	CcSEcCtD
Zaleplon—Ecchymosis—Capecitabine—esophageal cancer	0.00166	0.00419	CcSEcCtD
Zaleplon—Mouth ulceration—Capecitabine—esophageal cancer	0.00166	0.00419	CcSEcCtD
Zaleplon—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00165	0.00417	CcSEcCtD
Zaleplon—Breast disorder—Cisplatin—esophageal cancer	0.00164	0.00412	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00163	0.00411	CcSEcCtD
Zaleplon—Apnoea—Methotrexate—esophageal cancer	0.00162	0.00407	CcSEcCtD
Zaleplon—Abnormal vision—Capecitabine—esophageal cancer	0.0016	0.00404	CcSEcCtD
Zaleplon—Mental disability—Capecitabine—esophageal cancer	0.0016	0.00402	CcSEcCtD
Zaleplon—Speech disorder—Methotrexate—esophageal cancer	0.00159	0.00401	CcSEcCtD
Zaleplon—Ear pain—Capecitabine—esophageal cancer	0.00157	0.00394	CcSEcCtD
Zaleplon—Thrombophlebitis—Capecitabine—esophageal cancer	0.00154	0.00389	CcSEcCtD
Zaleplon—Diabetes mellitus—Capecitabine—esophageal cancer	0.00154	0.00387	CcSEcCtD
Zaleplon—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00153	0.00385	CcSEcCtD
Zaleplon—Photosensitivity—Capecitabine—esophageal cancer	0.00152	0.00383	CcSEcCtD
Zaleplon—Skin discolouration—Methotrexate—esophageal cancer	0.00152	0.00382	CcSEcCtD
Zaleplon—Swelling—Capecitabine—esophageal cancer	0.00151	0.00381	CcSEcCtD
Zaleplon—Gastroenteritis—Capecitabine—esophageal cancer	0.00151	0.0038	CcSEcCtD
Zaleplon—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00151	0.00379	CcSEcCtD
Zaleplon—Vascular purpura—Capecitabine—esophageal cancer	0.00149	0.00376	CcSEcCtD
Zaleplon—Deafness—Capecitabine—esophageal cancer	0.00149	0.00376	CcSEcCtD
Zaleplon—Glossitis—Methotrexate—esophageal cancer	0.00149	0.00374	CcSEcCtD
Zaleplon—Eye pain—Capecitabine—esophageal cancer	0.00148	0.00373	CcSEcCtD
Zaleplon—Hyperuricaemia—Methotrexate—esophageal cancer	0.00148	0.00372	CcSEcCtD
Zaleplon—Dysarthria—Methotrexate—esophageal cancer	0.00145	0.00365	CcSEcCtD
Zaleplon—Libido decreased—Capecitabine—esophageal cancer	0.00144	0.00363	CcSEcCtD
Zaleplon—Increased appetite—Capecitabine—esophageal cancer	0.00142	0.00358	CcSEcCtD
Zaleplon—Amnesia—Capecitabine—esophageal cancer	0.00142	0.00358	CcSEcCtD
Zaleplon—Thirst—Capecitabine—esophageal cancer	0.0014	0.00354	CcSEcCtD
Zaleplon—Dermatitis bullous—Capecitabine—esophageal cancer	0.0014	0.00352	CcSEcCtD
Zaleplon—Blood uric acid increased—Methotrexate—esophageal cancer	0.00139	0.00351	CcSEcCtD
Zaleplon—Purpura—Capecitabine—esophageal cancer	0.00139	0.00349	CcSEcCtD
Zaleplon—Arthritis—Capecitabine—esophageal cancer	0.00137	0.00346	CcSEcCtD
Zaleplon—Pulmonary embolism—Methotrexate—esophageal cancer	0.00137	0.00345	CcSEcCtD
Zaleplon—Vaginal inflammation—Methotrexate—esophageal cancer	0.00137	0.00345	CcSEcCtD
Zaleplon—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00137	0.00345	CcSEcCtD
Zaleplon—Stomatitis—Cisplatin—esophageal cancer	0.00136	0.00343	CcSEcCtD
Zaleplon—Conjunctivitis—Cisplatin—esophageal cancer	0.00136	0.00342	CcSEcCtD
Zaleplon—Cystitis noninfective—Methotrexate—esophageal cancer	0.00134	0.00337	CcSEcCtD
Zaleplon—Melaena—Methotrexate—esophageal cancer	0.00134	0.00337	CcSEcCtD
Zaleplon—Osteoarthritis—Capecitabine—esophageal cancer	0.00134	0.00336	CcSEcCtD
Zaleplon—Diplopia—Capecitabine—esophageal cancer	0.00134	0.00336	CcSEcCtD
Zaleplon—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00133	0.00334	CcSEcCtD
Zaleplon—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00132	0.00333	CcSEcCtD
Zaleplon—Cystitis—Methotrexate—esophageal cancer	0.00132	0.00333	CcSEcCtD
Zaleplon—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00132	0.00333	CcSEcCtD
Zaleplon—Migraine—Capecitabine—esophageal cancer	0.00131	0.00331	CcSEcCtD
Zaleplon—Vaginal infection—Methotrexate—esophageal cancer	0.00129	0.00326	CcSEcCtD
Zaleplon—Face oedema—Capecitabine—esophageal cancer	0.00129	0.00325	CcSEcCtD
Zaleplon—Irritability—Capecitabine—esophageal cancer	0.00127	0.00321	CcSEcCtD
Zaleplon—Urinary retention—Capecitabine—esophageal cancer	0.00127	0.0032	CcSEcCtD
Zaleplon—Mood swings—Capecitabine—esophageal cancer	0.00127	0.00319	CcSEcCtD
Zaleplon—Ataxia—Capecitabine—esophageal cancer	0.00126	0.00316	CcSEcCtD
Zaleplon—Bladder pain—Methotrexate—esophageal cancer	0.00124	0.00312	CcSEcCtD
Zaleplon—Ecchymosis—Methotrexate—esophageal cancer	0.00124	0.00312	CcSEcCtD
Zaleplon—Mouth ulceration—Methotrexate—esophageal cancer	0.00124	0.00312	CcSEcCtD
Zaleplon—Liver function test abnormal—Capecitabine—esophageal cancer	0.00123	0.00311	CcSEcCtD
Zaleplon—Dry skin—Capecitabine—esophageal cancer	0.00122	0.00308	CcSEcCtD
Zaleplon—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00122	0.00307	CcSEcCtD
Zaleplon—Visual impairment—Cisplatin—esophageal cancer	0.00121	0.00304	CcSEcCtD
Zaleplon—Breast disorder—Capecitabine—esophageal cancer	0.00121	0.00304	CcSEcCtD
Zaleplon—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0012	0.00303	CcSEcCtD
Zaleplon—Gastritis—Capecitabine—esophageal cancer	0.00118	0.00298	CcSEcCtD
Zaleplon—Muscular weakness—Capecitabine—esophageal cancer	0.00118	0.00297	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00118	0.00297	CcSEcCtD
Zaleplon—Eye disorder—Cisplatin—esophageal cancer	0.00117	0.00295	CcSEcCtD
Zaleplon—Tinnitus—Cisplatin—esophageal cancer	0.00117	0.00294	CcSEcCtD
Zaleplon—Lymphadenopathy—Methotrexate—esophageal cancer	0.00117	0.00294	CcSEcCtD
Zaleplon—Asthma—Capecitabine—esophageal cancer	0.00115	0.00291	CcSEcCtD
Zaleplon—Dysphagia—Capecitabine—esophageal cancer	0.00115	0.00291	CcSEcCtD
Zaleplon—Thrombophlebitis—Methotrexate—esophageal cancer	0.00115	0.00289	CcSEcCtD
Zaleplon—Diabetes mellitus—Methotrexate—esophageal cancer	0.00114	0.00288	CcSEcCtD
Zaleplon—Photosensitivity—Methotrexate—esophageal cancer	0.00113	0.00285	CcSEcCtD
Zaleplon—Immune system disorder—Cisplatin—esophageal cancer	0.00113	0.00285	CcSEcCtD
Zaleplon—Angina pectoris—Capecitabine—esophageal cancer	0.00112	0.00283	CcSEcCtD
Zaleplon—Bronchitis—Capecitabine—esophageal cancer	0.00111	0.0028	CcSEcCtD
Zaleplon—Alopecia—Cisplatin—esophageal cancer	0.00111	0.00279	CcSEcCtD
Zaleplon—Malnutrition—Cisplatin—esophageal cancer	0.00109	0.00275	CcSEcCtD
Zaleplon—Dysuria—Capecitabine—esophageal cancer	0.00108	0.00272	CcSEcCtD
Zaleplon—Flatulence—Cisplatin—esophageal cancer	0.00108	0.00271	CcSEcCtD
Zaleplon—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00105	0.00265	CcSEcCtD
Zaleplon—Weight increased—Capecitabine—esophageal cancer	0.00105	0.00265	CcSEcCtD
Zaleplon—Weight decreased—Capecitabine—esophageal cancer	0.00104	0.00263	CcSEcCtD
Zaleplon—Hyperglycaemia—Capecitabine—esophageal cancer	0.00104	0.00262	CcSEcCtD
Zaleplon—Pneumonia—Capecitabine—esophageal cancer	0.00104	0.00261	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00103	0.00259	CcSEcCtD
Zaleplon—Depression—Capecitabine—esophageal cancer	0.00103	0.00259	CcSEcCtD
Zaleplon—Tremor—Cisplatin—esophageal cancer	0.00102	0.00258	CcSEcCtD
Zaleplon—Ill-defined disorder—Cisplatin—esophageal cancer	0.00101	0.00255	CcSEcCtD
Zaleplon—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00101	0.00254	CcSEcCtD
Zaleplon—Anaemia—Cisplatin—esophageal cancer	0.00101	0.00254	CcSEcCtD
Zaleplon—Stomatitis—Capecitabine—esophageal cancer	0.001	0.00253	CcSEcCtD
Zaleplon—Conjunctivitis—Capecitabine—esophageal cancer	0.001	0.00252	CcSEcCtD
Zaleplon—Osteoarthritis—Methotrexate—esophageal cancer	0.000994	0.0025	CcSEcCtD
Zaleplon—Malaise—Cisplatin—esophageal cancer	0.000984	0.00248	CcSEcCtD
Zaleplon—Haematuria—Capecitabine—esophageal cancer	0.000981	0.00247	CcSEcCtD
Zaleplon—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000973	0.00245	CcSEcCtD
Zaleplon—Epistaxis—Capecitabine—esophageal cancer	0.000971	0.00245	CcSEcCtD
Zaleplon—Irritability—Methotrexate—esophageal cancer	0.000949	0.00239	CcSEcCtD
Zaleplon—Mood swings—Methotrexate—esophageal cancer	0.000942	0.00237	CcSEcCtD
Zaleplon—Ataxia—Methotrexate—esophageal cancer	0.000935	0.00236	CcSEcCtD
Zaleplon—Myalgia—Cisplatin—esophageal cancer	0.000929	0.00234	CcSEcCtD
Zaleplon—Anxiety—Cisplatin—esophageal cancer	0.000926	0.00233	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000923	0.00232	CcSEcCtD
Zaleplon—Hypoaesthesia—Capecitabine—esophageal cancer	0.000919	0.00232	CcSEcCtD
Zaleplon—Liver function test abnormal—Methotrexate—esophageal cancer	0.000918	0.00231	CcSEcCtD
Zaleplon—Discomfort—Cisplatin—esophageal cancer	0.000918	0.00231	CcSEcCtD
Zaleplon—Oedema peripheral—Capecitabine—esophageal cancer	0.00091	0.00229	CcSEcCtD
Zaleplon—Breast disorder—Methotrexate—esophageal cancer	0.000899	0.00226	CcSEcCtD
Zaleplon—Oedema—Cisplatin—esophageal cancer	0.000891	0.00224	CcSEcCtD
Zaleplon—Anaphylactic shock—Cisplatin—esophageal cancer	0.000891	0.00224	CcSEcCtD
Zaleplon—Visual impairment—Capecitabine—esophageal cancer	0.00089	0.00224	CcSEcCtD
Zaleplon—Nervous system disorder—Cisplatin—esophageal cancer	0.000873	0.0022	CcSEcCtD
Zaleplon—Tachycardia—Cisplatin—esophageal cancer	0.000869	0.00219	CcSEcCtD
Zaleplon—Skin disorder—Cisplatin—esophageal cancer	0.000865	0.00218	CcSEcCtD
Zaleplon—Eye disorder—Capecitabine—esophageal cancer	0.000864	0.00218	CcSEcCtD
Zaleplon—Tinnitus—Capecitabine—esophageal cancer	0.000862	0.00217	CcSEcCtD
Zaleplon—Hyperhidrosis—Cisplatin—esophageal cancer	0.000861	0.00217	CcSEcCtD
Zaleplon—Asthma—Methotrexate—esophageal cancer	0.000859	0.00216	CcSEcCtD
Zaleplon—Eosinophilia—Methotrexate—esophageal cancer	0.000851	0.00214	CcSEcCtD
Zaleplon—Anorexia—Cisplatin—esophageal cancer	0.000849	0.00214	CcSEcCtD
Zaleplon—Immune system disorder—Capecitabine—esophageal cancer	0.000835	0.0021	CcSEcCtD
Zaleplon—Hypotension—Cisplatin—esophageal cancer	0.000832	0.0021	CcSEcCtD
Zaleplon—Chills—Capecitabine—esophageal cancer	0.000829	0.00209	CcSEcCtD
Zaleplon—Alopecia—Capecitabine—esophageal cancer	0.000817	0.00206	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000811	0.00204	CcSEcCtD
Zaleplon—Mental disorder—Capecitabine—esophageal cancer	0.00081	0.00204	CcSEcCtD
Zaleplon—Malnutrition—Capecitabine—esophageal cancer	0.000804	0.00203	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—esophageal cancer	0.000804	0.00202	CcSEcCtD
Zaleplon—Paraesthesia—Cisplatin—esophageal cancer	0.0008	0.00201	CcSEcCtD
Zaleplon—Dyspnoea—Cisplatin—esophageal cancer	0.000794	0.002	CcSEcCtD
Zaleplon—Flatulence—Capecitabine—esophageal cancer	0.000793	0.002	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—esophageal cancer	0.000792	0.00199	CcSEcCtD
Zaleplon—Dysgeusia—Capecitabine—esophageal cancer	0.000788	0.00198	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000784	0.00198	CcSEcCtD
Zaleplon—Back pain—Capecitabine—esophageal cancer	0.000778	0.00196	CcSEcCtD
Zaleplon—Decreased appetite—Cisplatin—esophageal cancer	0.000774	0.00195	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—esophageal cancer	0.000771	0.00194	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000769	0.00194	CcSEcCtD
Zaleplon—Depression—Methotrexate—esophageal cancer	0.000764	0.00192	CcSEcCtD
Zaleplon—Pain—Cisplatin—esophageal cancer	0.000762	0.00192	CcSEcCtD
Zaleplon—Tremor—Capecitabine—esophageal cancer	0.000754	0.0019	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—esophageal cancer	0.000747	0.00188	CcSEcCtD
Zaleplon—Ill-defined disorder—Capecitabine—esophageal cancer	0.000746	0.00188	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—esophageal cancer	0.000745	0.00188	CcSEcCtD
Zaleplon—Anaemia—Capecitabine—esophageal cancer	0.000743	0.00187	CcSEcCtD
Zaleplon—Sweating—Methotrexate—esophageal cancer	0.000735	0.00185	CcSEcCtD
Zaleplon—Feeling abnormal—Cisplatin—esophageal cancer	0.000734	0.00185	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—esophageal cancer	0.000731	0.00184	CcSEcCtD
Zaleplon—Malaise—Capecitabine—esophageal cancer	0.000725	0.00183	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000725	0.00183	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—esophageal cancer	0.000723	0.00182	CcSEcCtD
Zaleplon—Vertigo—Capecitabine—esophageal cancer	0.000723	0.00182	CcSEcCtD
Zaleplon—Syncope—Capecitabine—esophageal cancer	0.000721	0.00182	CcSEcCtD
Zaleplon—Palpitations—Capecitabine—esophageal cancer	0.000711	0.00179	CcSEcCtD
Zaleplon—Loss of consciousness—Capecitabine—esophageal cancer	0.000707	0.00178	CcSEcCtD
Zaleplon—Body temperature increased—Cisplatin—esophageal cancer	0.000704	0.00177	CcSEcCtD
Zaleplon—Hypertension—Capecitabine—esophageal cancer	0.000694	0.00175	CcSEcCtD
Zaleplon—Myalgia—Capecitabine—esophageal cancer	0.000685	0.00172	CcSEcCtD
Zaleplon—Arthralgia—Capecitabine—esophageal cancer	0.000685	0.00172	CcSEcCtD
Zaleplon—Chest pain—Capecitabine—esophageal cancer	0.000685	0.00172	CcSEcCtD
Zaleplon—Anxiety—Capecitabine—esophageal cancer	0.000682	0.00172	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00068	0.00171	CcSEcCtD
Zaleplon—Discomfort—Capecitabine—esophageal cancer	0.000677	0.0017	CcSEcCtD
Zaleplon—Dry mouth—Capecitabine—esophageal cancer	0.00067	0.00169	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—esophageal cancer	0.000663	0.00167	CcSEcCtD
Zaleplon—Confusional state—Capecitabine—esophageal cancer	0.000662	0.00167	CcSEcCtD
Zaleplon—Oedema—Capecitabine—esophageal cancer	0.000656	0.00165	CcSEcCtD
Zaleplon—Shock—Capecitabine—esophageal cancer	0.000646	0.00163	CcSEcCtD
Zaleplon—Nervous system disorder—Capecitabine—esophageal cancer	0.000644	0.00162	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—esophageal cancer	0.000643	0.00162	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—esophageal cancer	0.000641	0.00162	CcSEcCtD
Zaleplon—Tachycardia—Capecitabine—esophageal cancer	0.000641	0.00161	CcSEcCtD
Zaleplon—Asthenia—Cisplatin—esophageal cancer	0.000639	0.00161	CcSEcCtD
Zaleplon—Skin disorder—Capecitabine—esophageal cancer	0.000638	0.00161	CcSEcCtD
Zaleplon—Hyperhidrosis—Capecitabine—esophageal cancer	0.000635	0.0016	CcSEcCtD
Zaleplon—Anorexia—Capecitabine—esophageal cancer	0.000626	0.00158	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—esophageal cancer	0.000621	0.00157	CcSEcCtD
Zaleplon—Chills—Methotrexate—esophageal cancer	0.000617	0.00155	CcSEcCtD
Zaleplon—Hypotension—Capecitabine—esophageal cancer	0.000613	0.00155	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—esophageal cancer	0.000608	0.00153	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—esophageal cancer	0.000603	0.00152	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—esophageal cancer	0.000599	0.00151	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000598	0.00151	CcSEcCtD
Zaleplon—Insomnia—Capecitabine—esophageal cancer	0.000594	0.0015	CcSEcCtD
Zaleplon—Paraesthesia—Capecitabine—esophageal cancer	0.000589	0.00148	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—esophageal cancer	0.000586	0.00148	CcSEcCtD
Zaleplon—Dyspnoea—Capecitabine—esophageal cancer	0.000585	0.00147	CcSEcCtD
Zaleplon—Back pain—Methotrexate—esophageal cancer	0.000579	0.00146	CcSEcCtD
Zaleplon—Dyspepsia—Capecitabine—esophageal cancer	0.000578	0.00146	CcSEcCtD
Zaleplon—TSPO—exocrine gland—esophageal cancer	0.000571	0.137	CbGeAlD
Zaleplon—Decreased appetite—Capecitabine—esophageal cancer	0.000571	0.00144	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000567	0.00143	CcSEcCtD
Zaleplon—Rash—Cisplatin—esophageal cancer	0.000562	0.00141	CcSEcCtD
Zaleplon—Pain—Capecitabine—esophageal cancer	0.000561	0.00141	CcSEcCtD
Zaleplon—Constipation—Capecitabine—esophageal cancer	0.000561	0.00141	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—esophageal cancer	0.000561	0.00141	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—esophageal cancer	0.000556	0.0014	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—esophageal cancer	0.000553	0.00139	CcSEcCtD
Zaleplon—Feeling abnormal—Capecitabine—esophageal cancer	0.000541	0.00136	CcSEcCtD
Zaleplon—Malaise—Methotrexate—esophageal cancer	0.00054	0.00136	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—esophageal cancer	0.000538	0.00136	CcSEcCtD
Zaleplon—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000537	0.00135	CcSEcCtD
Zaleplon—Nausea—Cisplatin—esophageal cancer	0.000529	0.00133	CcSEcCtD
Zaleplon—Urticaria—Capecitabine—esophageal cancer	0.000522	0.00131	CcSEcCtD
Zaleplon—Abdominal pain—Capecitabine—esophageal cancer	0.000519	0.00131	CcSEcCtD
Zaleplon—Body temperature increased—Capecitabine—esophageal cancer	0.000519	0.00131	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—esophageal cancer	0.00051	0.00128	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—esophageal cancer	0.00051	0.00128	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—esophageal cancer	0.00051	0.00128	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000506	0.00128	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—esophageal cancer	0.000504	0.00127	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—esophageal cancer	0.000493	0.00124	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—esophageal cancer	0.000489	0.00123	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—esophageal cancer	0.000479	0.00121	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—esophageal cancer	0.000475	0.0012	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—esophageal cancer	0.000472	0.00119	CcSEcCtD
Zaleplon—Asthenia—Capecitabine—esophageal cancer	0.000471	0.00119	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—esophageal cancer	0.000466	0.00117	CcSEcCtD
Zaleplon—Pruritus—Capecitabine—esophageal cancer	0.000464	0.00117	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—esophageal cancer	0.000457	0.00115	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000445	0.00112	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—esophageal cancer	0.000442	0.00111	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—esophageal cancer	0.000439	0.00111	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—esophageal cancer	0.000436	0.0011	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—esophageal cancer	0.000434	0.00109	CcSEcCtD
Zaleplon—Dizziness—Capecitabine—esophageal cancer	0.000434	0.00109	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—esophageal cancer	0.00043	0.00108	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—esophageal cancer	0.000425	0.00107	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000422	0.00106	CcSEcCtD
Zaleplon—Pain—Methotrexate—esophageal cancer	0.000418	0.00105	CcSEcCtD
Zaleplon—Rash—Capecitabine—esophageal cancer	0.000414	0.00104	CcSEcCtD
Zaleplon—Dermatitis—Capecitabine—esophageal cancer	0.000414	0.00104	CcSEcCtD
Zaleplon—Headache—Capecitabine—esophageal cancer	0.000411	0.00104	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—esophageal cancer	0.000403	0.00101	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—esophageal cancer	0.0004	0.00101	CcSEcCtD
Zaleplon—Nausea—Capecitabine—esophageal cancer	0.00039	0.000982	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—esophageal cancer	0.000388	0.000978	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—esophageal cancer	0.000386	0.000973	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—esophageal cancer	0.000386	0.000973	CcSEcCtD
Zaleplon—TSPO—neck—esophageal cancer	0.000365	0.0876	CbGeAlD
Zaleplon—GABRG2—Orphan transporters—CREBBP—esophageal cancer	0.000365	0.00169	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000363	0.00168	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000363	0.00168	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000363	0.00168	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000361	0.00167	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP1B1—esophageal cancer	0.000357	0.00165	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000356	0.00165	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000355	0.00164	CbGpPWpGaD
Zaleplon—AOX1—Disease—FKBP1A—esophageal cancer	0.000355	0.00164	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000353	0.00163	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000352	0.00163	CbGpPWpGaD
Zaleplon—Asthenia—Methotrexate—esophageal cancer	0.000351	0.000883	CcSEcCtD
Zaleplon—GABRA1—Neuronal System—ALDH2—esophageal cancer	0.000348	0.00161	CbGpPWpGaD
Zaleplon—AOX1—Disease—DOCK2—esophageal cancer	0.000347	0.00161	CbGpPWpGaD
Zaleplon—AOX1—Disease—WIF1—esophageal cancer	0.000347	0.00161	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000346	0.0016	CbGpPWpGaD
Zaleplon—Pruritus—Methotrexate—esophageal cancer	0.000346	0.000871	CcSEcCtD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000345	0.0016	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000344	0.0016	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CA1—esophageal cancer	0.000341	0.00158	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SLC10A2—esophageal cancer	0.000341	0.00158	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000341	0.00158	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.00034	0.00158	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00034	0.00158	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00034	0.00158	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000338	0.00157	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000338	0.00157	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP19A1—esophageal cancer	0.000335	0.00155	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000335	0.00155	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000332	0.00154	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000332	0.00154	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000331	0.00153	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000324	0.0015	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.000324	0.0015	CbGpPWpGaD
Zaleplon—Dizziness—Methotrexate—esophageal cancer	0.000323	0.000814	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.00032	0.00148	CbGpPWpGaD
Zaleplon—AOX1—Disease—CSNK1A1—esophageal cancer	0.00032	0.00148	CbGpPWpGaD
Zaleplon—GABRA1—Orphan transporters—CREBBP—esophageal cancer	0.000319	0.00148	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000317	0.00147	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CA2—esophageal cancer	0.000312	0.00145	CbGpPWpGaD
Zaleplon—Rash—Methotrexate—esophageal cancer	0.000308	0.000776	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—esophageal cancer	0.000308	0.000775	CcSEcCtD
Zaleplon—Headache—Methotrexate—esophageal cancer	0.000306	0.000771	CcSEcCtD
Zaleplon—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.000303	0.00141	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000303	0.0014	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000298	0.00138	CbGpPWpGaD
Zaleplon—Nausea—Methotrexate—esophageal cancer	0.00029	0.000731	CcSEcCtD
Zaleplon—AOX1—Metabolism—ADH7—esophageal cancer	0.00029	0.00134	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PLCE1—esophageal cancer	0.00029	0.00134	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.00029	0.00134	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.00029	0.00134	CbGpPWpGaD
Zaleplon—AOX1—bronchus—esophageal cancer	0.000287	0.0687	CbGeAlD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000283	0.00131	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00028	0.0013	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000278	0.00129	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000275	0.00127	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000275	0.00127	CbGpPWpGaD
Zaleplon—AOX1—Disease—ELMO1—esophageal cancer	0.000269	0.00125	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000265	0.00123	CbGpPWpGaD
Zaleplon—AOX1—Disease—GSTO1—esophageal cancer	0.000263	0.00122	CbGpPWpGaD
Zaleplon—AOX1—Disease—TPI1—esophageal cancer	0.000263	0.00122	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000262	0.00121	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000258	0.0012	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000258	0.0012	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000258	0.00119	CbGpPWpGaD
Zaleplon—AOX1—trachea—esophageal cancer	0.000257	0.0617	CbGeAlD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000256	0.00119	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000256	0.00119	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ADH1B—esophageal cancer	0.000254	0.00118	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000254	0.00118	CbGpPWpGaD
Zaleplon—AOX1—Disease—ALDOB—esophageal cancer	0.000252	0.00117	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000252	0.00117	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00025	0.00116	CbGpPWpGaD
Zaleplon—TSPO—epithelium—esophageal cancer	0.000249	0.0596	CbGeAlD
Zaleplon—TSPO—bronchus—esophageal cancer	0.000245	0.0587	CbGeAlD
Zaleplon—AOX1—Metabolism—TYMP—esophageal cancer	0.000243	0.00113	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000242	0.00112	CbGpPWpGaD
Zaleplon—AOX1—Disease—GAPDH—esophageal cancer	0.000242	0.00112	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIST1H2BM—esophageal cancer	0.000242	0.00112	CbGpPWpGaD
Zaleplon—TSPO—smooth muscle tissue—esophageal cancer	0.00024	0.0574	CbGeAlD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000239	0.00111	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP26A1—esophageal cancer	0.000237	0.0011	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000234	0.00108	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000232	0.00108	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000231	0.00107	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALOX15—esophageal cancer	0.000231	0.00107	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000228	0.00106	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000226	0.00105	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000225	0.00104	CbGpPWpGaD
Zaleplon—AOX1—digestive system—esophageal cancer	0.000221	0.0531	CbGeAlD
Zaleplon—AOX1—Metabolism—GSTO1—esophageal cancer	0.00022	0.00102	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TPI1—esophageal cancer	0.00022	0.00102	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00022	0.00102	CbGpPWpGaD
Zaleplon—TSPO—trachea—esophageal cancer	0.00022	0.0527	CbGeAlD
Zaleplon—AOX1—Disease—XIAP—esophageal cancer	0.000214	0.000992	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000212	0.000983	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALDOB—esophageal cancer	0.000211	0.000977	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000209	0.000967	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000206	0.000954	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GAPDH—esophageal cancer	0.000203	0.000941	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CRABP1—esophageal cancer	0.000201	0.000932	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000199	0.000924	CbGpPWpGaD
Zaleplon—AOX1—Disease—B2M—esophageal cancer	0.000199	0.000922	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000194	0.000899	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000191	0.000887	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GNG7—esophageal cancer	0.000191	0.000887	CbGpPWpGaD
Zaleplon—AOX1—Disease—ENO1—esophageal cancer	0.000191	0.000884	CbGpPWpGaD
Zaleplon—TSPO—digestive system—esophageal cancer	0.000189	0.0453	CbGeAlD
Zaleplon—AOX1—Disease—PSME2—esophageal cancer	0.000188	0.000871	CbGpPWpGaD
Zaleplon—AOX1—Disease—PSME1—esophageal cancer	0.000188	0.000871	CbGpPWpGaD
Zaleplon—GABRB2—lung—esophageal cancer	0.000187	0.0448	CbGeAlD
Zaleplon—AOX1—lung—esophageal cancer	0.000185	0.0443	CbGeAlD
Zaleplon—AOX1—Disease—CALR—esophageal cancer	0.00018	0.000836	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BLVRB—esophageal cancer	0.00018	0.000835	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC52A3—esophageal cancer	0.00018	0.000835	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ALDH2—esophageal cancer	0.000179	0.000831	CbGpPWpGaD
Zaleplon—AOX1—Disease—FBXW7—esophageal cancer	0.000175	0.000809	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTT1—esophageal cancer	0.000171	0.00079	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2A6—esophageal cancer	0.000169	0.000781	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS1—esophageal cancer	0.00016	0.00074	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ENO1—esophageal cancer	0.00016	0.00074	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000158	0.000733	CbGpPWpGaD
Zaleplon—TSPO—lung—esophageal cancer	0.000158	0.0379	CbGeAlD
Zaleplon—AOX1—Metabolism—PSME2—esophageal cancer	0.000157	0.00073	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PSME1—esophageal cancer	0.000157	0.00073	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000157	0.000729	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA1—esophageal cancer	0.000153	0.00071	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC10A2—esophageal cancer	0.000153	0.00071	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000152	0.000705	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00015	0.000697	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000149	0.000689	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000146	0.000676	CbGpPWpGaD
Zaleplon—GABRB3—lung—esophageal cancer	0.000143	0.0344	CbGeAlD
Zaleplon—GABRA2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000143	0.000661	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000142	0.000656	CbGpPWpGaD
Zaleplon—AOX1—Disease—TGFBR2—esophageal cancer	0.000141	0.000654	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000141	0.000653	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CA2—esophageal cancer	0.00014	0.00065	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000139	0.000644	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000137	0.000634	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000136	0.00063	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1B1—esophageal cancer	0.000136	0.00063	CbGpPWpGaD
Zaleplon—AOX1—Disease—SMAD4—esophageal cancer	0.000134	0.000619	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000133	0.000618	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PLCE1—esophageal cancer	0.00013	0.000604	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADH7—esophageal cancer	0.00013	0.000604	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.00013	0.000604	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.00013	0.000604	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP19A1—esophageal cancer	0.000128	0.000592	CbGpPWpGaD
Zaleplon—AOX1—lymph node—esophageal cancer	0.000126	0.0303	CbGeAlD
Zaleplon—GABRA1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000122	0.000563	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00012	0.000556	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000118	0.000548	CbGpPWpGaD
Zaleplon—CYP3A5—digestive system—esophageal cancer	0.000117	0.0281	CbGeAlD
Zaleplon—GABRA2—lymph node—esophageal cancer	0.000117	0.028	CbGeAlD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000117	0.000541	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMOX1—esophageal cancer	0.000117	0.00054	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ADH1B—esophageal cancer	0.000114	0.00053	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000113	0.000522	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ABCB1—esophageal cancer	0.000112	0.000518	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000111	0.000515	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA1—esophageal cancer	0.000111	0.000513	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000111	0.000513	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIF1A—esophageal cancer	0.000109	0.000507	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TYMP—esophageal cancer	0.000109	0.000506	CbGpPWpGaD
Zaleplon—TSPO—lymph node—esophageal cancer	0.000108	0.0259	CbGeAlD
Zaleplon—CYP3A7—Metabolism—CYP26A1—esophageal cancer	0.000106	0.000492	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALOX15—esophageal cancer	0.000104	0.00048	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CA2—esophageal cancer	0.000101	0.00047	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS2—esophageal cancer	9.94e-05	0.000461	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTO1—esophageal cancer	9.88e-05	0.000458	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TPI1—esophageal cancer	9.88e-05	0.000458	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOTCH1—esophageal cancer	9.85e-05	0.000456	CbGpPWpGaD
Zaleplon—CYP3A5—lung—esophageal cancer	9.78e-05	0.0234	CbGeAlD
Zaleplon—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.75e-05	0.000452	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDOB—esophageal cancer	9.47e-05	0.000439	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADH7—esophageal cancer	9.42e-05	0.000437	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PLCE1—esophageal cancer	9.42e-05	0.000437	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.14e-05	0.000424	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GAPDH—esophageal cancer	9.11e-05	0.000422	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.08e-05	0.000421	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CRABP1—esophageal cancer	9.03e-05	0.000419	CbGpPWpGaD
Zaleplon—AOX1—Disease—CREBBP—esophageal cancer	8.93e-05	0.000414	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.92e-05	0.000413	CbGpPWpGaD
Zaleplon—CYP3A4—digestive system—esophageal cancer	8.79e-05	0.0211	CbGeAlD
Zaleplon—CYP3A7—Metabolism—GNG7—esophageal cancer	8.59e-05	0.000398	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ADH1B—esophageal cancer	8.26e-05	0.000383	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ALDH2—esophageal cancer	8.05e-05	0.000373	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOS3—esophageal cancer	7.99e-05	0.00037	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TYMP—esophageal cancer	7.89e-05	0.000366	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.8e-05	0.000361	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP26A1—esophageal cancer	7.68e-05	0.000356	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—esophageal cancer	7.66e-05	0.000355	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2A6—esophageal cancer	7.57e-05	0.000351	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALOX15—esophageal cancer	7.48e-05	0.000347	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CREBBP—esophageal cancer	7.48e-05	0.000347	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—esophageal cancer	7.48e-05	0.000347	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—esophageal cancer	7.31e-05	0.000339	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS1—esophageal cancer	7.18e-05	0.000333	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ENO1—esophageal cancer	7.18e-05	0.000333	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTO1—esophageal cancer	7.14e-05	0.000331	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TPI1—esophageal cancer	7.14e-05	0.000331	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PSME1—esophageal cancer	7.07e-05	0.000328	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PSME2—esophageal cancer	7.07e-05	0.000328	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDOB—esophageal cancer	6.84e-05	0.000317	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NOS3—esophageal cancer	6.7e-05	0.00031	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GAPDH—esophageal cancer	6.59e-05	0.000305	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CRABP1—esophageal cancer	6.53e-05	0.000303	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN1A—esophageal cancer	6.39e-05	0.000296	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNG7—esophageal cancer	6.21e-05	0.000288	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—esophageal cancer	6.12e-05	0.000284	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1B1—esophageal cancer	6.1e-05	0.000283	CbGpPWpGaD
Zaleplon—AOX1—Disease—EP300—esophageal cancer	6.08e-05	0.000282	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.06e-05	0.000281	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.06e-05	0.000281	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ALDH2—esophageal cancer	5.82e-05	0.00027	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP19A1—esophageal cancer	5.74e-05	0.000266	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—esophageal cancer	5.54e-05	0.000257	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2A6—esophageal cancer	5.47e-05	0.000254	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—esophageal cancer	5.3e-05	0.000246	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMOX1—esophageal cancer	5.23e-05	0.000243	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ENO1—esophageal cancer	5.19e-05	0.00024	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS1—esophageal cancer	5.19e-05	0.00024	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—esophageal cancer	5.18e-05	0.00024	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA1—esophageal cancer	5.15e-05	0.000239	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.15e-05	0.000239	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PSME1—esophageal cancer	5.11e-05	0.000237	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PSME2—esophageal cancer	5.11e-05	0.000237	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—EP300—esophageal cancer	5.09e-05	0.000236	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ABCB1—esophageal cancer	5.02e-05	0.000233	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CA2—esophageal cancer	4.71e-05	0.000218	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—esophageal cancer	4.5e-05	0.000208	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1B1—esophageal cancer	4.41e-05	0.000204	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.38e-05	0.000203	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADH7—esophageal cancer	4.38e-05	0.000203	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP19A1—esophageal cancer	4.15e-05	0.000192	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.84e-05	0.000178	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMOX1—esophageal cancer	3.78e-05	0.000175	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—esophageal cancer	3.77e-05	0.000175	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TYMP—esophageal cancer	3.67e-05	0.00017	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ABCB1—esophageal cancer	3.63e-05	0.000168	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.57e-05	0.000165	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.48e-05	0.000161	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CREBBP—esophageal cancer	3.36e-05	0.000156	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.32e-05	0.000154	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TPI1—esophageal cancer	3.32e-05	0.000154	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.18e-05	0.000147	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.06e-05	0.000142	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.04e-05	0.000141	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NOS3—esophageal cancer	3.01e-05	0.000139	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNG7—esophageal cancer	2.89e-05	0.000134	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.75e-05	0.000127	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.71e-05	0.000125	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.57e-05	0.000119	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.54e-05	0.000118	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.43e-05	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.41e-05	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ENO1—esophageal cancer	2.41e-05	0.000112	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSME2—esophageal cancer	2.38e-05	0.00011	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PSME1—esophageal cancer	2.38e-05	0.00011	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—EP300—esophageal cancer	2.29e-05	0.000106	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NOS3—esophageal cancer	2.17e-05	0.000101	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.05e-05	9.5e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.99e-05	9.21e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.93e-05	8.93e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.76e-05	8.15e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.69e-05	7.84e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.69e-05	7.82e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—EP300—esophageal cancer	1.65e-05	7.66e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.22e-05	5.67e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.13e-05	5.23e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NOS3—esophageal cancer	1.01e-05	4.68e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—esophageal cancer	9.24e-06	4.28e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—EP300—esophageal cancer	7.69e-06	3.56e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—esophageal cancer	5.69e-06	2.63e-05	CbGpPWpGaD
